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Long-term results of renal transplantation in children. The results of
renal transplantation in 37 children, 3 through 16 years of age, who
received transplants prior to June, 1970 in our center, were examined.
Twenty-three received kidneys from living-related donors and 14 re-
ceived kidneys from cadaver donors. Patient survival rates were 78% at
10 years and 68% at 20 to 26 years. Graft survival rates were 56% at 10
years, 31% at 20 years, and 23% at 22 to 26 years. Twenty children
received on or more retranspiants. At follow-up, 23 (62%) of the
patients had functiáning grafts and two (5%) were undergoing dialysis.
Cataracts, hypertension, and aseptic necrosis of bone were the most
common medical complications and most of the patients were more
than two standard deviations below average height. Most enjoyed good
rehabilitation, however: more than 70% were employed or performing
full time housework, more than 50% were married, 24% had children,
and all had normal activity at least part of the time. These results,
achieved with immunosuppressive methods now considered obsolete,
indicate that renal transplantation is a satisfactory long-term treatment
for children with renal failure.
The first renal transplant between identical twins was per-
formed in 1954, and the first successful transplant between
non-identical individuals was performed in 1959 [1]. Although
the results in the early years of transplantation were generally
poor, a number of patients have survived for prolonged periods
after receiving a transplant. some with the original kidney still
functioning. There is little information regarding the long-term
results of transplantation, in either children or adults. The
present report describes results in children who received trans-
plants in our institution from 1964 to 1970, and therefore have
been followed for at least twenty years. Patient and graft
survival rates are analyzed, the status of children ten years after
transplantation is examined and their subsequent course de-
scribed, and the rehabilitation, growth, and renal function of
children surviving more than twenty years after transplantation
are considered.
Methods
Patients
Thirty-seven children (16 boys, 21 girls), ages 3 through 16
years (mean 9.4 years) received renal transplants between April
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1964 and May 1970. Seven children were less than six years of
age. The causes of renal failure were chronic glomerulonephri-
tis in 15 children, reflux nephropathy in 4, bilateral Wilms'
tumor in 4, dysplasia in 3, rapidly progressive glomerulonephri-
tis in 3, obstructive uropathy in 2, and HenOch-Schönlein
nephritis, hemolytic-uremic syndrome, cystinosis, congenital
nephrotic syndrome, medullary cystic disease, and nail-patella
syndrome in 1 each. Fourteen children received kidneys from
cadaver donors and 23 children received kidneys from living
related donors, of whom 17 were parents, 2, siblings (1 HLA
identical), 2, grandparents, 1, half-sibling, and 1, uncle.
Details of the surgical techniques and immunosuppressive
regimen have been published previously [2]. Immunosuppres-
sion at transplantation was azathioprine, 2 mg/kg, which was
continued indefinitely, and prednisone, 2 mg/kg, with subse-
quent tapering of the dose; recipients of cadaver kidneys also
received irradiation of the graft and actinomycin C for three
days. Rejection episodes were treated with increased doses of
prednisone, irradiation of the graft, and actinomycin C. Sple-
nectomies were performed in 32 of the children.
Twenty patients received second transplants and three pa-
tients received third transplants. Nineteen of these transplants
were performed using cadaver grafts and immunosuppression
included cyclosporine after seven of the transplants.
All surviving patients were followed for at least twenty years.
Patient and graft survival rates were calculated for the 26 year
period of this report. Survival rates for the first 20 years
represent actual rates whereas rates between 20 and 26 years
were calculated by actuarial methods [3]. In the analysis of graft
survival, patients dying with functioning grafts were considered
to have undergone graft failure.
Follow-up information was obtained on all surviving patients
in June 1990, and included assessments of general health,
medical complications, serum creatinine level, height, employ-
ment status, and marital status. All of the patients were
interviewed, either in person or by telephone, and were asked
to define their level of activity by one of the five categories
described in the Karnovsky activity scale [4]. The ages of the
patients were 23 to 40 years (mean 32.0 years).
Growth was assessed by changes in standard deviation scores
for height [5]. The height of each child was measured at
transplantation and when he or she stopped growing and was
expressed as the number of standard deviations from the mean
height of normal children of the same age and sex.
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Table 1. Causes of death in relation to time after transplantation
No. of deaths by time period after
Cause
transplantation
<1 year 1—3 years 10—26 years
Infection 5 ia 1
Operative I — —
Wilms' tumor — 1 —
Cerebral hemorrhage — — 1
Skin cancer — —
Hyperkalemia (dialysis) — —
Statistical analysis
Data are expressed as means so. Comparison of means
between groups was by Students unpaired t-test and compari-
son of means within groups was by Student's paired t-test.
Results
Twenty-five of the 37 children were alive at follow-up, 20 to
26 years after transplantation. Cumulative patient survival rates
were 78% at 10 years and 68% at 20 to 26 years (Fig. 1). The
survival rate at 20 years was 78% for children who received
living-related donor transplants and 50% for children who
received cadaver donor transplants.
Infection was the primary cause of death, accounting for six
deaths occurring within the first three years after transplanta-
tion and one death occurring 13 years after transplantation
(Table 1). Seven deaths occurred in recipients of cadaver
kidneys, five of whom were less than six years of age. Three of
these children had previous Wilms' tumors.
Cumulative graft survival rates were 56% at 10 years, 31% at
20 years, and 23% at 22 to 26 years (Fig. 1). The survival rate at
20 years was 35% for living-related donor grafts and 21% for
cadaver grafts. Actuarial graft survival rates of the 23 retrans-
plants were 49% at 10 years and 37% at 15 years.
The status of the children ten years after transplantation and
at follow-up is shown in Figure 2. Ten of the 20 primary grafts
functioning at ten years subsequently failed, in three instances
after patients discontinued immunosuppressive drugs. Most of
the patients whose grafts failed received successful retrans-
plants, however, and the percentage of children with function-
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Fig. 2. The status of37 children ten years after transplantation and at
follow-up.
ing grafts decreased only slightly during the second decade,
from 70% to 62%.
In the patients whose primary grafts continued to function,
the mean serum creatinine level increased from 1.18 0.24
mg/dl at ten years to 2.06 1.53 mgldl at follow-up (P = 0.10).
Two of the patients, one who received a graft from an HLA-
identical donor, and the other who received a graft from a
haplo-identical donor, had taken no immunosuppressive drugs
for ten years. The mean serum creatinine level of the patients
with functioning second or third transplants at follow-up was
1.22 0.36 mg/dl.
The medical complications in the 25 surviving patients at
follow-up are listed in Table 2. Five of the 23 patients with
functioning grafts had symptomatic medical problems, aseptic
necrosis of bone in four and relapsing pancreatitis in one, and
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Fig. 1. Patient and graft survival rates for 37
25 children after transplantation. Numbers above the
lines refer to number of patients or grafts at risk.
Status Number of patients at
10 years 20—26 years
Functioning first 20 10
graft
7
Functioning second 6 5
or third graft
Dialysis 3 1
2
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Table 2. Complications in the 25 patients at follow-up
Number of patients
Cataracts 14
Hypertension 5
Aseptic necrosis 4
Relapsing pancreatitis I
Ureteral obstruction I
Skeletal deformities I
Urinary tract infection 1
Arrhythmia 1
Seizure disorder 1
Polymyositis 1
Depression I
one of the two patients undergoing chronic dialysis was symp-
tomatic with polymyositis and a mild depressive disorder. All of
the patients were active, achieving activity ratings of 90 to 100
or 80 to 89 on the Karnovsky activity scale (Table 3). Fifteen of
the 23 patients with functioning grafts and one of the two
patients undergoing dialysis were employed or performing
full-time housework (Table 4). More than one-half of the
patients were married and six had children (Table 4).
The mean height standard deviation score of the children at
transplantation was —1.82 1.77 and at follow-up was —2.43
1.40, a change which just reached statistical significance (P =
0.05). The mean height standard deviation score did not change
between transplantation and follow-up in the patients whose
primary grafts continued to function (—2.14 1.64 and —2.17
1.76, respectively), but decreased significantly in those who
required retransplants or were undergoing dialysis (—1.61
1.88 and —2.60 1.17, respectively, P <0.05).
Discussion
In our center, 68% of children who had received renal
transplants more than twenty years previously were alive, 27%
with the original kidney still functioning. Most of the patients
were healthy and leading productive lives, demonstrating that
transplantation can be a successful long-term treatment for
children with renal failure.
A number of transplant centers have reported their results
extending more than ten years after transplantation [6—16], but
there is little information on survival past twenty years, either
in adults or children. The longest reported experience is that of
transplants between identical twins in Boston [91; for thirty
patients who received transplants between 1954 and 1976,
actuarial patient and graft survival rates at 25 years were 66%
and 55%, respectively. For recipients of non-twin transplants,
20-year actuarial patient and graft survival rates of 53% and
19%, respectively, have been reported [15]. In the most exten-
sive pediatric experience [16], 45% of patients were alive and
26% of grafts were functioning 10 to 25 years after transplanta-
tion.
In our center, the mortality rate was high during the first year
after transplantation, in an era when high doses of corticoste-
roids were used to treat rejection episodes and infections
complications were common. Most of the early deaths occurred
in recipients of cadaver grafts, and the highest mortality rates
were in groups known to be at greatest risk, children less than
six years of age [17] and children with previous Wilms' tumors
[181. The fact that most of the children underwent splenectomy
Table 3. Physical activity of the 25 patients at follow-up according to
Karnovsky category
Patients with Patients Patients
primary with on
grafts retransplants dialysis
Activity scale Number of patients
90—100 Almost normal 8 10
physical activity
1
80—89 Normal activity at 2 3
least part of the
time
1
70—79 Only self-care 0 0
activities
0
40—69 Requires help in 0 0
self-care
0
1—39 Institutionalized 0 0 0
Table 4. Employment and marital status of the 25 patients at
follow-up
Patients w
primar
grafts
ith Patients
y with
retransplants
Patients
on
dialysis
Number of patients
Employment status
Employed 7 8 0
Full-time housework 1 1 1
Unemployed 2 4 1
Marital status
Married 5 7 1
Divorced 1 0 0
Single 4 6 1
Patients with children 3 3 0
may also have contributed to the high mortality rate, but there
was no difference in the incidence of infectious deaths in
splenectomized and non-splenectomized patients, and after we
adopted a policy limiting the amount of immunosuppression
used to treat rejection episodes [19], the mortality rate following
second and third transplants was low.
The late mortality rate, in patients surviving more than ten
years after transplantation, was also low, 14%, which compares
with mortality rates of 20% to 30% reported in adult patients
during the second decade after transplantation [10, 12, 14, 15].
The lower mortality rate in our patients could simply be the
result of sampling error in a small group or could reflect the
younger age of our patients, since cardiovascular disease,
which is the most frequent cause of late deaths in adults
following transplantation [10—12, 14, 15] was the cause of death
in only one of our children. In the only report of long-term
pediatric survivors [16], the mortality rate after ten years was
21%, and although none of the deaths was attributed to cardio-
vascular causes, three patients had either coronary artery
disease or cerebrovascular disease at follow-up.
Although the mortality rate after ten years was low, graft loss
after ten years, primarily from chronic rejection, was a continu-
ing problem. It has previously been shown that there is a
constant rate of graft loss after the second year following
transplantation [20] although these calculations were based on
data extending less than ten years. The results in our small
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series suggest that the same rate of graft loss continues through
the second decade after transplantation, and might imply that
all grafts will eventually be lost. Other centers have reported a
lower rate of graft loss during the second decade, however, and
the maintenance of stable renal function in the majority of
long-term survivors [11, 12, 14, 15]. In comparing our results
with those from adult programs, it may be pertinent that 30% of
late graft losses in our center occurred in patients who discon-
tinued immunosuppressive therapy, reflecting the fact that
patient non-compliance is particularly prevalent in the pediatric
population [21]. Two of our patients who had discontinued
immunosuppressive drugs ten years previously had good renal
function at follow-up, however, indicating that immunologic
tolerance to transplanted kidneys can develop.
For patients whose original grafts failed, dialysis and retrans-
plantation were often effective modalities for achieving a good
long-term result. As noted by others [22], the success rate of
second and third transplants was similar to that of first trans-
plants, and 35% of our patients had functioning retranspiants at
follow-up. The incidence of symptomatic medical problems,
such as aseptic necrosis, and of severe growth retardation was
higher in patients who required transplants than in those whose
primary grafts continued to function, however, and the out-
come in two patients who required prolonged dialysis after
multiple failed transplants was death in one case, and depres-
sion and a difficult adjustment problem in the other.
There are few data on the rehabilitation and quality of life of
long-term transplant survivors, although in a recent study of
patients with grafts functioning more than 20 years, 10 of 12
reported unrestricted activity and an excellent quality of life
[23]. In studies of patients with grafts functioning more than ten
years [7, 16, 24], 77% to 98% have been employed, 25% to 43%
have been married, 19% to 30% have had children, and 87%
have reported normal activity at least part of the time. Growth
retardation, which is a consequence of renal failure before
transplantation and of corticosteroid therapy after transplanta-
tion, has been a common problem in long-term pediatric survi-
vors [25], but its effect on quality of life has not been evaluated.
In our study the great majority of children followed longer than
20 years after transplantation were asymptomatic, active, and
employed or performing full-time housework and more than
50% were married. Rehabilitation was better in patients with
functioning grafts than in those undergoing dialysis, which
accords with previous data [26], and tended to be better in
patients with primary grafts than in those who had received
more than one transplant. Quality of life issues were not
specifically examined, but in this study, as well as in a study of
children followed more than ten years after transplantation [24],
almost all of the patients expressed satisfaction with their lives.
Finally, it should be noted that the long-term outcomes we
are reporting are the result of transplants performed in a
relatively primitive era of transplantation, when five-year ca-
daver graft survival rates in our center and others were 35 to
40%. At present, with improved immunosuppressive protocols,
including the use of cyclosporine, and other advances in patient
care, five-year patient and graft survival rates of 90% and 70%,
respectively, are being achieved in recipients of cadaver grafts
[27]. In addition, the use of cyclosporine has reduced the need
for prednisone, and some children are growing at normal, or
even accelerated rates after transplantation [28]. If these im-
proved short-term outcomes are extended into the second
decade after transplantation, it can be anticipated that children
currently undergoing transplantation will enjoy even better
long-term survival and rehabilitation than the subjects of this
report.
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